Unique ID issued by UMIN | UMIN000004058 |
---|---|
Receipt number | R000004808 |
Scientific Title | Maintenance of baroreflex sensitivity during intravenous sedation with a combination of propofol and midazolam |
Date of disclosure of the study information | 2010/08/25 |
Last modified on | 2012/02/20 08:51:47 |
Maintenance of baroreflex sensitivity during intravenous sedation with a combination of propofol and midazolam
Baroreflex sensitivity during intravenous sedation
Maintenance of baroreflex sensitivity during intravenous sedation with a combination of propofol and midazolam
Baroreflex sensitivity during intravenous sedation
Japan |
mentally handicapped patient
dental phobia
Dental medicine |
Others
NO
This study examines whether baroreflex sensitivity during intravenous sedation with a combination of propofol and midazolam is maintained at the same level as that with propofol only. Furthermore, we evaluate the safety of combination sedation on cardiovascular control systems at doses appropriate for mentally handicapped patients to accept medical treatment.
Safety,Efficacy
For analysis of spontaneous baroreflex sensitivity, we examined continuous finger arterial pressure and electrocardiograms to detect sequence changes in the R-R interval with parallel changes in arterial pressure. Our software selected all of the sequences of three or more successive heart beats in which there were concordant increases or decreases in systolic blood pressure and R-R intervals. A linear regression was applied to each of the sequences, and the mean slope during each condition was assessed as baroreflex sensitivity.
Interventional
Parallel
Non-randomized
Single blind -participants are blinded
Active
2
Treatment
Medicine |
We also analyzed the effect of intravenous sedation with a combination of propofol and midazolam during dental treatment of a group of mentally handicapped adult patients to evaluate the maintenance of blood pressure in such subjects.
Intravenous sedation using propofol only during dental treatment of another group of handicapped patients was used as a control.
16 | years-old | <= |
Not applicable |
Male and Female
Only patients scheduled for dental treatment under intravenous sedative were recruited for this study. Written informed consent from parents or legal guardians was obtained following careful explanation of the study's procedure, risk, and benefits.
This study was performed according to guidelines set by the Declaration of Helsinki and was approved by the Institutional Review Board on Human Experiments of Matsumoto Dental University.
Patients with serious circulatory or respiratory diseases, epilepsy, egg or buckwheat allergies, or any other serious chronic diseases were excluded from experiments.
12
1st name | |
Middle name | |
Last name | Sumida Sachi |
Matsumoto Dental University
Department of Special Patients and Oral Care
1780,Goubara,Hirooka,Siojirisi,
1st name | |
Middle name | |
Last name |
Matsumoto Dental University
Department of Special Patients and Oral Care
sumineko@po.mdu.ac.jp
Matsumoto Dental University
Nagano Society for the Promotion of Science
Non profit foundation
NO
2010 | Year | 08 | Month | 25 | Day |
Unpublished
Completed
2010 | Year | 07 | Month | 30 | Day |
2010 | Year | 08 | Month | 01 | Day |
2010 | Year | 08 | Month | 17 | Day |
2012 | Year | 02 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004808